Literature DB >> 7755557

Thimet oligopeptidase specificity: evidence of preferential cleavage near the C-terminus and product inhibition from kinetic analysis of peptide hydrolysis.

C G Knight1, P M Dando, A J Barrett.   

Abstract

The substrate-size specificity of human thimet oligopeptidase (EC 3.4.24.15) was investigated with oligomers of glycyl-prolyl-leucine (GPL)n where n = 2, 3, 4 and 5. These peptides were cleaved only at Leu-Gly bonds to give GPL as the single final product. Hydrolysis was most rapid with (GPL)3 and slowest with (GPL)5. The more water-soluble oligomers of Gly-Hyp-Leu showed the same trend. (Gly-Hyp-Leu)6 was not hydrolysed, consistent with the previous finding that substrates larger than 17 amino acids are not cleaved by thimet oligopeptidase. The cleavage of (GPL)3 to GPL fitted a sequential first-order model. First-order kinetics were unexpected as the initial substrate concentration was greater than Km. The anomaly was also seen during the cleavage of bradykinin and neurotensin, and in these cases first-order behaviour was due to potent competitive inhibition by the C-terminal product. The sequential mechanism for (GPL)3 breakdown by thimet oligopeptidase does not discriminate between initial cleavages towards the N- or C-terminus. As isoleucine is an unfavourable residue in P1, substrates were made in which selected leucine residues were replaced by isoleucine. GPL--GPI--GPL (where--represents the bond between the tripeptide units) was resistant to hydrolysis and GPI--GPL--GPL was cleaved only at the -Leu-Gly- bond. Experiments with isoleucine-containing analogues of (Gly-Hyp-Leu)4 showed that thimet oligopeptidase preferred to cleave these peptides near the C-terminus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755557      PMCID: PMC1136855          DOI: 10.1042/bj3080145

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

1.  A selective assay for endooligopeptidase A based on the cleavage of fluorogenic substrate structurally related to enkephalin.

Authors:  L Juliano; J R Chagas; I Y Hirata; E Carmona; M Sucupira; E S Oliveira; E B Oliveira; A C Camargo
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

Review 2.  Oligopeptidases, and the emergence of the prolyl oligopeptidase family.

Authors:  A J Barrett; N D Rawlings
Journal:  Biol Chem Hoppe Seyler       Date:  1992-07

3.  Characterization of the bacterial metalloendopeptidase pitrilysin by use of a continuous fluorescence assay.

Authors:  A Anastasi; C G Knight; A J Barrett
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

4.  An alternative quenched fluorescence substrate for Pz-peptidase.

Authors:  U Tisljar; C G Knight; A J Barrett
Journal:  Anal Biochem       Date:  1990-04       Impact factor: 3.365

5.  Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides.

Authors:  T G Chu; M Orlowski
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

6.  PZ-peptidase from chick embryos. Purification, properties, and action on collagen peptides.

Authors:  T I Morales; J F Woessner
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

7.  Analysis of the importance of arginine 102 in neutral endopeptidase (enkephalinase) catalysis.

Authors:  Y A Kim; B Shriver; T Quay; L B Hersh
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

8.  Structure/function relationships in the inhibition of thimet oligopeptidase by carboxyphenylpropyl-peptides.

Authors:  C G Knight; A J Barrett
Journal:  FEBS Lett       Date:  1991-12-09       Impact factor: 4.124

9.  Human thimet oligopeptidase.

Authors:  P M Dando; M A Brown; A J Barrett
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

  9 in total
  8 in total

1.  Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase.

Authors:  A C Camargo; M D Gomes; A P Reichl; E S Ferro; S Jacchieri; I Y Hirata; L Juliano
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

2.  Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.

Authors:  Jan H Kessler; Selina Khan; Ulrike Seifert; Sylvie Le Gall; K Martin Chow; Annette Paschen; Sandra A Bres-Vloemans; Arnoud de Ru; Nadine van Montfoort; Kees L M C Franken; Willemien E Benckhuijsen; Jill M Brooks; Thorbald van Hall; Kallol Ray; Arend Mulder; Ilias I N Doxiadis; Paul F van Swieten; Hermen S Overkleeft; Annik Prat; Birgitta Tomkinson; Jacques Neefjes; Peter M Kloetzel; David W Rodgers; Louis B Hersh; Jan W Drijfhout; Peter A van Veelen; Ferry Ossendorp; Cornelis J M Melief
Journal:  Nat Immunol       Date:  2010-12-12       Impact factor: 25.606

3.  Rat thimet oligopeptidase: large-scale expression in Escherichia coli and characterization of the recombinant enzyme.

Authors:  N McKie; P M Dando; M A Brown; A J Barrett
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

4.  Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells.

Authors:  Denise A Berti; Cain Morano; Lilian C Russo; Leandro M Castro; Fernanda M Cunha; Xin Zhang; Juan Sironi; Clécio F Klitzke; Emer S Ferro; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

5.  Thimet oligopeptidase expression is differentially regulated in neuroendocrine and spermatid cell lines by transcription factor binding to SRY (sex-determining region Y), CAAT and CREB (cAMP-response-element-binding protein) promoter consensus sequences.

Authors:  Lesley S Morrison; Adrian R Pierotti
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

6.  Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase).

Authors:  Sandra I Kim; Amanda Pabon; Todd A Swanson; Marc J Glucksman
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 7.  Advances with RNA interference in Alzheimer's disease research.

Authors:  Shun Chen; Xuemei Ge; Yinghui Chen; Nan Lv; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-02-22       Impact factor: 4.162

8.  CLCAs - a family of metalloproteases of intriguing phylogenetic distribution and with cases of substituted catalytic sites.

Authors:  Anna Lenart; Małgorzata Dudkiewicz; Marcin Grynberg; Krzysztof Pawłowski
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.